Kulvinder Kochar Kaur, MD et al. 2025. Improved Management of Type 2 Diabetes Mellitus with Empigliflozin and Hypertension with Renin-Angiotensin System Inhibitors and Manidipine, Preferentially of Dihydropyridones to Optimize Cardiovascular Outcomes. Obesity Research. (Jan. 2025), 1–13. DOI:https://doi.org/10.17140/oroj.2025.v11.i01.pp01-13.1425.